| Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse SJ Lee, JP Klein, AJ Barrett, O Ringden, JH Antin, JY Cahn, MH Carabasi, ... Blood, The Journal of the American Society of Hematology 100 (2), 406-414, 2002 | 665 | 2002 |
| Luspatercept in patients with lower-risk myelodysplastic syndromes P Fenaux, U Platzbecker, GJ Mufti, G Garcia-Manero, R Buckstein, ... New England Journal of Medicine 382 (2), 140-151, 2020 | 488 | 2020 |
| Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study S O'Brien, JA Jones, SE Coutre, AR Mato, P Hillmen, C Tam, A Österborg, ... The Lancet Oncology 17 (10), 1409-1418, 2016 | 399 | 2016 |
| Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere … J Marsh, H Schrezenmeier, P Marin, O Ilhan, P Ljungman, S McCann, ... Blood, The Journal of the American Society of Hematology 93 (7), 2191-2195, 1999 | 279 | 1999 |
| COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ... Journal of hematology & oncology 14 (1), 168, 2021 | 269 | 2021 |
| Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors V Gupta, M Eapen, R Brazauskas, J Carreras, M Aljurf, RP Gale, GA Hale, ... Haematologica 95 (12), 2119, 2010 | 205 | 2010 |
| Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy … AF Dagnew, O Ilhan, WS Lee, D Woszczyk, JY Kwak, S Bowcock, ... The Lancet infectious diseases 19 (9), 988-1000, 2019 | 203 | 2019 |
| Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia SJ Lee, M Kukreja, T Wang, SA Giralt, J Szer, M Arora, AE Woolfrey, ... Blood, The Journal of the American Society of Hematology 112 (8), 3500-3507, 2008 | 173 | 2008 |
| Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial U Jaeger, M Trneny, H Melzer, M Praxmarer, W Nawarawong, DB Yehuda, ... haematologica 100 (7), 955, 2015 | 103 | 2015 |
| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ... The Lancet 399 (10326), 719-728, 2022 | 100 | 2022 |
| Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony‐stimulating factor (rhG‐CSF): a randomized evaluation of different doses … T Demirer, M Ayli, M Ozcan, N Gunel, R Haznedar, M Dagli, T Fen, ... British journal of haematology 116 (2), 468-474, 2002 | 94 | 2002 |
| Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study AS Michallet, M Aktan, W Hiddemann, O Ilhan, P Johansson, K Laribi, ... haematologica 103 (4), 698, 2018 | 86 | 2018 |
| Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma TS Fenske, PN Hari, J Carreras, MJ Zhang, RT Kamble, BJ Bolwell, ... Biology of Blood and Marrow Transplantation 15 (11), 1455-1464, 2009 | 73 | 2009 |
| The Medalist trial: results of a phase 3, randomized, double-blind, placebo-controlled study of luspatercept to treat anemia in patients with very low-, low-, or intermediate … P Fenaux, U Platzbecker, GJ Mufti, G Garcia-Manero, R Buckstein, ... Blood 132, 1, 2018 | 71 | 2018 |
| Efficacy and safety of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic leukemia with 17p deletion: results from the phase II … S O’Brien, JA Jones, S Coutre, AR Mato, P Hillmen, C Tam, A Osterborg, ... Blood 124 (21), 327, 2014 | 71 | 2014 |
| HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t (8; 21) in first complete remission: collaborative study between the … RF Schlenk, MC Pasquini, WS Pérez, MJ Zhang, J Krauter, JH Antin, ... Biology of Blood and Marrow Transplantation 14 (2), 187-196, 2008 | 68 | 2008 |
| Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the … P Lugtenburg, I Avivi, H Berenschot, O Ilhan, JP Marolleau, A Nagler, ... Haematologica 102 (11), 1913, 2017 | 67 | 2017 |
| Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis E Kaya, M Keklik, M Şencan, M Yilmaz, A Keskin, I Kiki, MA Erkurt, ... Transfusion and Apheresis Science 48 (3), 349-352, 2013 | 65 | 2013 |
| A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host … C Ustun, O Arslan, M Beksaç, H Koç, G Gurman, T Ozcelik, B Yilmaz, ... Biology of Blood and Marrow Transplantation 5 (1), 28-35, 1999 | 61 | 1999 |
| Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation PJ Shaughnessy, BJ Bolwell, K van Besien, M Mistrik, A Grigg, A Dodds, ... Bone marrow transplantation 45 (6), 1068-1076, 2010 | 58 | 2010 |
Hamdi AkanProfessor of Haematology, Ankara University在 medicine.ankara.edu.tr 的电子邮件经过验证
